Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CRM

Salesforce

$106.75

-2.05 (-1.88%)

, BLMN

Bloomin' Brands

$20.83

0.29 (1.41%)

10:34
11/22/17
11/22
10:34
11/22/17
10:34
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

CRM

Salesforce

$106.75

-2.05 (-1.88%)

BLMN

Bloomin' Brands

$20.83

0.29 (1.41%)

HALO

Halozyme

$19.20

0.5 (2.67%)

MNK

Mallinckrodt

$20.99

-0.4 (-1.87%)

CYTK

Cytokinetics

$8.25

-2.85 (-25.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 14

    Dec

HALO

Halozyme

$19.20

0.5 (2.67%)

04:51
11/22/17
11/22
04:51
11/22/17
04:51
Downgrade
Halozyme rating change at Barclays »

Halozyme assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 14

    Dec

Over a week ago
HALO

Halozyme

$18.61

-0.48 (-2.51%)

08:39
11/10/17
11/10
08:39
11/10/17
08:39
Hot Stocks
Halozyme to present nonclinical data on PEGPH20 at SITC meeting »

Halozyme will present…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 14

    Dec

HALO

Halozyme

$16.84

-0.17 (-1.00%)

16:44
11/07/17
11/07
16:44
11/07/17
16:44
Earnings
Halozyme raises FY17 revenue view to $265M-$280M from $245M-$260M 

FY17 consensus $258.49M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 28

    Nov

  • 14

    Dec

HALO

Halozyme

$16.84

-0.17 (-1.00%)

16:42
11/07/17
11/07
16:42
11/07/17
16:42
Earnings
Halozyme reports Q3 EPS 2c, may not compare to consensus (10c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 28

    Nov

  • 14

    Dec

HALO

Halozyme

$17.59

0.4 (2.33%)

, JNJ

Johnson & Johnson

$140.00

-1.78 (-1.26%)

08:40
10/31/17
10/31
08:40
10/31/17
08:40
Hot Stocks
Halozyme announces Janssen Biotech began Phase 3 clinical trials for Darzalex »

Halozyme Therapeutics…

HALO

Halozyme

$17.59

0.4 (2.33%)

JNJ

Johnson & Johnson

$140.00

-1.78 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

HALO

Halozyme

$17.55

-0.27 (-1.52%)

08:34
10/24/17
10/24
08:34
10/24/17
08:34
Hot Stocks
Halozyme announces clinical trial evaluating PEGPH20 »

Halozyme Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

Over a month ago
XNCR

Xencor

$23.16

-0.6 (-2.53%)

, MRUS

Merus

$20.51

-0.77 (-3.62%)

04:55
10/18/17
10/18
04:55
10/18/17
04:55
Conference/Events
Biotechnology Innovation Organization to hold a forum »

BIO Investor Forum is…

XNCR

Xencor

$23.16

-0.6 (-2.53%)

MRUS

Merus

$20.51

-0.77 (-3.62%)

ZYME

Zymeworks

$9.00

0.03 (0.33%)

OREX

Orexigen

$1.89

0.06 (3.28%)

RBCN

Rubicon

$8.31

0.137 (1.68%)

HALO

Halozyme

$17.74

-0.12 (-0.67%)

RDHL

RedHill Biopharma

$8.85

-0.16 (-1.78%)

ABBV

AbbVie

$92.17

1.13 (1.24%)

CTSO

CytoSorbents

$6.05

-0.1 (-1.63%)

CMA

Comerica

$74.80

-0.54 (-0.72%)

PT

Portugal Telecom

RLMD

Relmada Therapeutics

$0.90

0.05 (5.88%)

CERC

Cerecor

$1.04

-0.05 (-4.59%)

BMY

Bristol-Myers

$64.18

0.53 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 20

    Oct

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

HALO

Halozyme

$17.74

-0.12 (-0.67%)

04:55
10/18/17
10/18
04:55
10/18/17
04:55
Conference/Events
Halozyme management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 07

    Nov

XNCR

Xencor

$23.76

-0.13 (-0.54%)

, MRUS

Merus

$21.28

0.27 (1.29%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Biotechnology Innovation Organization to hold a forum »

BIO Investor Forum is…

XNCR

Xencor

$23.76

-0.13 (-0.54%)

MRUS

Merus

$21.28

0.27 (1.29%)

ZYME

Zymeworks

$8.97

0.0678 (0.76%)

OREX

Orexigen

$1.83

-0.1307 (-6.67%)

RBCN

Rubicon

$8.17

-0.21 (-2.51%)

HALO

Halozyme

$17.86

0.39 (2.23%)

RDHL

RedHill Biopharma

$9.01

-0.05 (-0.55%)

ABBV

AbbVie

$91.04

0.37 (0.41%)

CTSO

CytoSorbents

$6.15

-0.1 (-1.60%)

CMA

Comerica

$75.34

-0.21 (-0.28%)

PT

Portugal Telecom

RLMD

Relmada Therapeutics

$0.85

-0.05 (-5.56%)

CERC

Cerecor

BMY

Bristol-Myers

$63.65

-1.64 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 18

    Oct

  • 20

    Oct

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.